Study: Vitamin B5 Ingredient Lowers LDL Cholesterol
Pantesin, a highly absorbable vitamin B5 (pantethine) from Kyowa Hakko (New York City), may significantly lower low-density lipoprotein (LDL) cholesterol in humans, according to research published in the journal Nutrition Research.
Pantesin, a highly absorbable vitamin B5 (pantethine) from Kyowa Hakko (New York City), may significantly lower low-density lipoprotein (LDL) cholesterol in humans, according to research published in the journal Nutrition Research.
For 16 weeks, 120 participants with low to moderate risk of heart disease were assigned to 600 mg of Pantesin or an equivalent placebo daily. By the end of the study, the Pantesin group experienced an average 4 mg/dL reduction of LDL cholesterol compared to the placebo group.
While such a change may seem small at plain sight, the researchers noted that “for each 1 mg reduction in LDL cholesterol, there is a concomitant 1% reduction in overall future cardiovascular disease risk.”
Sirio Pharma launches line of ready-to-market organic gummies and softgels called PureOrganix
August 26th 2024The new line is made up of three gummies and one softgel that are formulated to meet stringent EU-Organic certification criteria, and target women’s health, metabolic health, and heart health.
SourceOne Global Partners to distribute Qualitas Health’s microalgae omega-3 ingredient globally
August 15th 2024SourceOne Global Partners has announced a partnership with Qualitas Health Inc., (dba iwi life) to introduce the company’s trademarked AlmegaPL microalgae omega-3 ingredient to the global marketplace.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
